(NASDAQ: IVF) Invo Fertility's forecast annual revenue growth rate of 50.51% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Invo Fertility's revenue in 2026 is $7,531,121.On average, 2 Wall Street analysts forecast IVF's revenue for 2026 to be $26,380,835, with the lowest IVF revenue forecast at $25,598,660, and the highest IVF revenue forecast at $27,426,241. On average, 2 Wall Street analysts forecast IVF's revenue for 2027 to be $41,680,867, with the lowest IVF revenue forecast at $40,442,424, and the highest IVF revenue forecast at $43,330,452.
In 2028, IVF is forecast to generate $65,855,569 in revenue, with the lowest revenue forecast at $63,900,133 and the highest revenue forecast at $68,462,816.